Barometer Capital Management Inc. Decreases Stock Holdings in Lam Research Corporation $LRCX

Barometer Capital Management Inc. lowered its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 8.0% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 35,210 shares of the semiconductor company’s stock after selling 3,050 shares during the period. Lam Research makes up approximately 1.2% of Barometer Capital Management Inc.’s holdings, making the stock its 28th biggest position. Barometer Capital Management Inc.’s holdings in Lam Research were worth $4,715,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Howard Hughes Medical Institute purchased a new stake in Lam Research in the second quarter worth approximately $27,000. Sound Income Strategies LLC purchased a new stake in Lam Research during the 3rd quarter valued at $41,000. Tripletail Wealth Management LLC bought a new position in shares of Lam Research during the 3rd quarter valued at $44,000. Strategic Wealth Investment Group LLC bought a new position in shares of Lam Research during the 2nd quarter valued at $29,000. Finally, Delos Wealth Advisors LLC purchased a new position in shares of Lam Research in the 2nd quarter worth $30,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Long‑term collaboration with IBM to advance sub‑1nm logic scaling — strengthens Lam’s position on next‑generation logic and EUV-related process work, expanding addressable content per wafer fab cycle. IBM and Lam Research Announce Collaboration to Advance Sub‑1nm Logic Scaling
• Positive Sentiment: S&P 100 inclusion, recent strong results and supportive market notes should boost demand — index addition and re‑rating flows plus solid Jan quarter results and guidance increase passive and active buying pressure. Lam Research jumps amid semiconductor-equipment rebound and S&P 100 addition
• Positive Sentiment: Industry capex outlook remains strong — banks raised chip‑gear spending estimates and analyst notes point to sustained WFE upside, supporting equipment vendors like Lam. Chip Gear Spending Shows No Signs Of Slowing
• Positive Sentiment: Short interest in LRCX fell meaningfully in February (≈20.7% decline), reducing immediate short‑squeeze risk and removing some downward pressure on the shares.
• Positive Sentiment: Analyst support and higher price targets remain widespread (median targets above current levels; Barclays nudged its PT higher), providing additional directional support. Barclays raises LRCX price target
• Neutral Sentiment: Independent equity research continues to highlight a favorable WFE cycle and Lam’s potential for share gains — useful context for medium‑term investors but not an immediate catalyst. Lam Research: The Setup Keeps Getting Stronger
• Negative Sentiment: Hazeltree reports hedge funds ramping short bets amid geopolitical and private‑credit concerns — broader market volatility and flow shifts could pressure cyclicals like Lam in risk‑off episodes. Hazeltree Finds Hedge Funds Ramp Up Short Bets
• Negative Sentiment: Notable insider selling activity reported across senior executives over the past six months — raises a governance/optics flag for some investors and can weigh on sentiment. Quiver Quant on LRCX insider activity

Lam Research Stock Performance

Shares of LRCX opened at $218.87 on Thursday. The business has a 50-day simple moving average of $223.44 and a two-hundred day simple moving average of $171.66. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 52 week low of $56.32 and a 52 week high of $256.68. The stock has a market cap of $273.32 billion, a price-to-earnings ratio of 44.85, a PEG ratio of 2.32 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The firm had revenue of $5.34 billion for the quarter, compared to analysts’ expectations of $5.23 billion. During the same period in the previous year, the firm earned $0.91 EPS. The business’s quarterly revenue was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, analysts expect that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be given a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Wednesday, March 4th. Lam Research’s dividend payout ratio (DPR) is presently 21.31%.

Insider Activity

In related news, insider Ava Harter sold 1,500 shares of Lam Research stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $222.66, for a total transaction of $333,990.00. Following the transaction, the insider owned 53,205 shares in the company, valued at approximately $11,846,625.30. The trade was a 2.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Eric Brandt sold 35,000 shares of the company’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the completion of the transaction, the director directly owned 253,705 shares of the company’s stock, valued at $57,235,848. This represents a 12.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 130,886 shares of company stock worth $29,658,802 in the last three months. Company insiders own 0.31% of the company’s stock.

Wall Street Analyst Weigh In

LRCX has been the subject of a number of research reports. TD Cowen upped their price objective on Lam Research from $170.00 to $290.00 and gave the company a “buy” rating in a research report on Thursday, January 29th. The Goldman Sachs Group set a $262.00 price target on Lam Research and gave the company a “buy” rating in a research note on Thursday, January 29th. Jefferies Financial Group reaffirmed a “buy” rating and set a $200.00 price target (up from $175.00) on shares of Lam Research in a research report on Monday, December 15th. UBS Group set a $300.00 price objective on shares of Lam Research in a research note on Thursday, January 29th. Finally, Wells Fargo & Company raised their price objective on shares of Lam Research from $250.00 to $290.00 and gave the stock an “overweight” rating in a report on Thursday, January 29th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $245.35.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.